Epigral Ltd's Q3FY25 Quarter Results
- 28 Jan 2025
Result Summary
- Epigral Ltd reported a 2.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 36.9%.
- Its expenses for the quarter were down by 2.3% QoQ and up 23.9% YoY.
- The net profit increased 27.5% QoQ and increased 111.1% YoY.
- The earnings per share (EPS) of Epigral Ltd stood at 24.3 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 649.10 | 631.61 | 473.98 | 2.8% | 36.9% |
Total Expenses | 495.57 | 507.20 | 399.82 | -2.3% | 23.9% |
Profit Before Tax | 153.53 | 124.41 | 74.16 | 23.4% | 107.0% |
Tax | 49.99 | 43.88 | 24.85 | 13.9% | 101.2% |
Profit After Tax | 103.63 | 81.30 | 49.08 | 27.5% | 111.1% |
Earnings Per Share | 24.30 | 19.60 | 11.80 | 24.0% | 105.9% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Epigral Ltd is a company operating within [industry information not available]. As of the latest quarter, Epigral has not made any recent major developments publicly known. The company continues to focus on its core products and services, catering to its established market. Further details regarding its specific offerings and strategic initiatives are not readily accessible from the provided data or within the timeframe of this report. Despite the lack of specific information regarding Epigral Ltd's industry and market position, the company's financial data presents a clear depiction of its fiscal health over the recent quarters.
Revenue
In the third quarter of fiscal year 2025 (Q3FY25), Epigral Ltd reported a total income of ₹649.10 crores. This represents a 2.8% increase from the previous quarter (Q2FY25) where total income was ₹631.61 crores, and a significant 36.9% increase from the same quarter in the previous year (Q3FY24) when total income stood at ₹473.98 crores. The consistent growth in revenue over both the quarterly and yearly comparisons suggests a robust performance in the company's income generation capabilities for this period under review.
Profitability
Epigral Ltd's profitability metrics show notable improvement in Q3FY25. The company's profit before tax was ₹153.53 crores, marking a 23.4% increase from ₹124.41 crores in Q2FY25. Compared to Q3FY24, where profit before tax was ₹74.16 crores, there is a 107.0% increase. The profit after tax for Q3FY25 is ₹103.63 crores, which is 27.5% higher than the preceding quarter's ₹81.30 crores, and 111.1% higher than the previous year’s ₹49.08 crores for the same period. Earnings per share have also improved, rising from ₹19.60 in Q2FY25 to ₹24.30 in Q3FY25, and from ₹11.80 in Q3FY24 to the current level, reflecting an increase of 24.0% QoQ and 105.9% YoY.
Operating Metrics
The operating metrics of Epigral Ltd for Q3FY25 highlight a reduction in total expenses, which decreased by 2.3% from the previous quarter, coming down from ₹507.20 crores in Q2FY25 to ₹495.57 crores. When compared to the same quarter in the previous year (Q3FY24), total expenses have increased by 23.9%, rising from ₹399.82 crores. The tax for Q3FY25 was recorded at ₹49.99 crores, which shows an increase of 13.9% from Q2FY25's ₹43.88 crores and 101.2% from Q3FY24's ₹24.85 crores. These metrics demonstrate the company's operational cost management and tax liabilities over the respective periods.
